HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD

Author:

Vietzen Hannes1ORCID,Furlano Philippe L.1ORCID,Cornelissen Jan J.2,Böhmig Georg A.3ORCID,Jaksch Peter4,Puchhammer-Stöckl Elisabeth1

Affiliation:

1. 1Center for Virology, Medical University of Vienna, Vienna, Austria

2. 2Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands

3. 3Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria

4. 4Division of Thoracic Surgery, Medical University of Vienna, Vienna, Austria

Abstract

Abstract Primary Epstein-Barr virus (EBV) infections may cause infectious mononucleosis (IM), whereas EBV reactivations in solid organ and hematopoietic stem cell transplant recipients are associated with posttransplantation lymphoproliferative disorders (PTLDs). It is still unclear why only a minority of primary EBV-infected individuals develop IM, and why only some patients progress to EBV+PTLD after transplantation. We now investigated whether nonclassic human leukocyte antigen E (HLA-E)–restricted immune responses have a significant impact on the development of EBV diseases in the individual host. On the basis of a large study cohort of 1404 patients and controls as well as on functional natural killer (NK) and CD8+ T-cell analyses, we could demonstrate that the highly expressed HLA-E∗0103/0103 genotype is protective against IM, due to the induction of potent EBV BZLF1-specific HLA-E–restricted CD8+ T-cell responses, which efficiently prevent the in vitro viral dissemination. Furthermore, we provide evidence that the risk of symptomatic EBV reactivations in immunocompetent individuals as well as in immunocompromised transplant recipients depends on variations in the inhibitory NKG2A/LMP-1/HLA-E axis. We show that EBV strains encoding for the specific LMP-1 peptide variants GGDPHLPTL or GGDPPLPTL, presented by HLA-E, elicit strong inhibitory NKG2A+ NK and CD8+ T-cell responses. The presence of EBV strains encoding for both peptides was highly associated with symptomatic EBV reactivations. The further progression to EBV+PTLD was highly associated with the presence of both peptide-encoding EBV strains and the expression of HLA-E∗0103/0103 in the host. Thus, HLA-E–restricted immune responses and the NKG2A/LMP-1/HLA-E axis are novel predictive markers for EBV+PTLD in transplant recipients and should be considered for future EBV vaccine design.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference33 articles.

1. The high burden of hospitalizations for primary EBV infection: a 6-year prospective survey in a French hospital;Hocqueloux;Clin Microbiol Infect,2015

2. Primary Epstein-Barr virus infection with and without infectious mononucleosis;Rostgaard;PLoS One,2019

3. Estimating the global burden of Epstein–Barr virus-related cancers;Wong;J Cancer Res Clin Oncol,2022

4. Prognosis and outcomes of patients with post-transplant lymphoproliferative disorder: a single center retrospective review;Pearse;Blood,2020

5. Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients;Jørgensen;PLoS One,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3